Curasight's Board of Directors
All of the Board members and persons discharging managerial responsibilities can be reached via the Company’s address, Ole Maaløes Vej 3, 2200 Copenhagen, Denmark.
Kirsten Drejer
Chairperson of the Board 2024- (member 2021-)
Born 1956, MSc, PhD
- Board member: Zealand Pharma, Bioneer, Malin Ltd, Resother Pharma and other biotech companies (2017-)
- CEO and co-founder, Symphogen A/S (2000-2016)
- Corporate Facilitator, Novo Nordisk A/S (1997-2000)
- Director of Diabetes Discovery, Novo Nordisk A/S (1992-1996)
- Head of Diabetes Pharmacology, Novo Nordisk A/S (1991-1992)
- PhD in pharmacology – The Danish University of Pharmaceutical Science, Copenhagen University.
Lars Trolle
Deputy chairman of the Board 2020- (Chairman 2014-2020)
Born 1967, B.Sc.
- CTO at MedTrace Pharma A/S (2024-2025)
- CDO at UNEEG medical A/S (2019-2023)
- CEO of Contura International A/S (2015 – 2018)
- CEO of DDD-Diagnostic A/S (2009 – 2015) – specialists in development and supply of gamma cameras to nuclear medicine
- Studied for BBa in Organization and Strategy at Copenhagen Business School plus executive education programs at IMD and Columbia Business School
- B.Sc Mechanical and Plastic Engineering - Elsinore Technical University
Charlotte Vedel
Member of the Board 2020-
Born 1968, MSc, PhD
- Advisor, Committee and Board member
- European Patent Attorney
- COO and co-founder, Lactobio A/S (2017-2024)
- CTO, Novo Nordisk Foundation, Center for Biosustainability (2017-2018)
- Corporate VP, R&D, Innovation management, Head of IP strategy, DuPont Nutrition Biosciences (2011-2017)
- Corporate VP, IP, Danisco A/S (2006-2011)
- Department manager, R&D, Santaris Pharma A/S (2001-2003)
- R&D specialist, Novo Nordisk A/S (1994-2001)
- MSc in biomedicine – Ulster University and PhD in biotechnology – Technical University of Denmark (DTU).
Ulrich Krasilnikoff
Member of the Board, CEO & CFO 2016-
Born 1967, MBA, Dipl. Ing., CPA
- CEO & CFO Curasight A/S (2016-)
- EVP Biofac Group (pharma; 2015-2016)
- Ass. Partner Capidea Capital Fund (Private equity; 2012-2014)
- Partner/EVP Mezzanin Capital A/S (Private equity; 2004-2012)
- EVP HNC Group A/S (2002-2004)
- Board member; Curasight A/S, Primodan A/S and other companies.
- Certified Public Accountant (CPA) and B.Sc in finance and accounting – Copenhagen Business School (CBS)
- MBA - University of Southern Denmark, Diploma in Engineering from DTU - Technical University of Denmark (DTU)
Andreas Kjær
Member of the Board, CSO and co-founder 2013-
Born 1963, MD, PhD, DMSc, MBA
- CSO and co-founder Curasight (2013-)
- Professor at the University of Copenhagen, Chief Physician at Rigshospitalet - the National University Hospital of Denmark (research focused on molecular imaging with PET and PET/MRI and theranostics in cancer)
- Head of Cluster for Molecular Imaging (CMI) (2004-)
- Holder of an ERC Advanced Grant, has published more than 500 peer-review articles, has received numerous prestigious scientific awards over the years.
- Member of the Danish Academy of Technica Sciences (ATV) (2015-)
- Founder FlouGuide (2018)
- Co-founder Minerva Imaging (2011).
- Founding Editor in Chief Diagnostics (2011-) and International Associate Editor Journal of Nuclear Medicine (2019-)
- MD, PhD, DMSc - University of Copenhagen, Master of Business Administration (MBA) - Copenhagen Business School (CBS)